BRPI0816350A2 - Composições orais, produtos e métodos de uso - Google Patents

Composições orais, produtos e métodos de uso

Info

Publication number
BRPI0816350A2
BRPI0816350A2 BRPI0816350-2A2A BRPI0816350A BRPI0816350A2 BR PI0816350 A2 BRPI0816350 A2 BR PI0816350A2 BR PI0816350 A BRPI0816350 A BR PI0816350A BR PI0816350 A2 BRPI0816350 A2 BR PI0816350A2
Authority
BR
Brazil
Prior art keywords
products
methods
oral compositions
oral
compositions
Prior art date
Application number
BRPI0816350-2A2A
Other languages
English (en)
Inventor
Jeffrey Warren Clymer
Paul John Rennie
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BRPI0816350A2 publication Critical patent/BRPI0816350A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0816350-2A2A 2007-09-04 2008-09-04 Composições orais, produtos e métodos de uso BRPI0816350A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96741207P 2007-09-04 2007-09-04
PCT/US2008/075199 WO2009032888A2 (en) 2007-09-04 2008-09-04 Oral compositions, products, and methods of use

Publications (1)

Publication Number Publication Date
BRPI0816350A2 true BRPI0816350A2 (pt) 2015-02-24

Family

ID=40090141

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0816350-2A2A BRPI0816350A2 (pt) 2007-09-04 2008-09-04 Composições orais, produtos e métodos de uso
BRPI0816465 BRPI0816465A2 (pt) 2007-09-04 2008-09-04 Métodos para tratamento ou prevenção de infecções do trato respiratório que compreendem a administração de colecalciferol

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0816465 BRPI0816465A2 (pt) 2007-09-04 2008-09-04 Métodos para tratamento ou prevenção de infecções do trato respiratório que compreendem a administração de colecalciferol

Country Status (9)

Country Link
US (2) US20090060878A1 (pt)
EP (2) EP2194989A1 (pt)
CN (2) CN101801389A (pt)
AU (2) AU2008296310A1 (pt)
BR (2) BRPI0816350A2 (pt)
CA (2) CA2698514A1 (pt)
MX (2) MX2010002410A (pt)
RU (2) RU2479316C2 (pt)
WO (2) WO2009032887A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8178106B2 (en) * 2009-03-30 2012-05-15 Mary Kay Inc. Topical skin care formulations
EP2723330B1 (de) * 2011-08-19 2015-07-08 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH Vasokonstriktorhaltiges kombinationstherapeutikum
WO2013052101A1 (en) * 2011-10-03 2013-04-11 Kelly Foods Corporation Probiotic composition for pets and method of providing the same
US20130101634A1 (en) * 2011-10-12 2013-04-25 Deerland Enzymes, Inc. Compositions and methods for reducing microbial overgrowth in the small intestines
US20150353876A1 (en) * 2012-02-10 2015-12-10 Mc Food Specialties Inc. Fruit-based food and beverage containing components derived from amla
US20130273182A1 (en) * 2012-04-12 2013-10-17 Po-Lun Wang A Herbal Extract for Treating Fatty Liver Disease and a Medication Thereof
US9616124B2 (en) * 2014-07-17 2017-04-11 Jonathan S. Nimitz Antiviral supplement compositions and methods of use
WO2016037166A1 (en) * 2014-09-07 2016-03-10 Yu Zhang Novel anti-oxidant compositions and methods of delivery
WO2016195526A1 (ru) * 2015-06-03 2016-12-08 Людмила Борисовна ТИМИРОВА Успокаивающая композиция, понижающая возбудимость при половой охоте у кошек и собак
DE102016105369A1 (de) * 2016-03-22 2017-09-28 Bernd Büter Erzeugnis, insbesondere Nahrungsmittelzusatz, Futtermittel oder Tierfutterzusatz und Verfahren zu dessen Herstellung
CN109640705A (zh) * 2016-08-04 2019-04-16 西雅图咖米公司 矿物质组合物及其制备和使用方法
WO2018169497A1 (en) * 2017-03-17 2018-09-20 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Spray formulation comprising cholecalciferol (vitamin d3) with improved stability
US11419882B2 (en) 2017-06-08 2022-08-23 Allergyintellect, Inc Vitamin D compounds and methods of using the same
CN108813608A (zh) * 2018-05-25 2018-11-16 陕西黄龙国寿堂生物工程有限公司 一种沙棘刺五加膏的制作方法
CN109549993A (zh) * 2018-12-29 2019-04-02 西安高科陕西金方药业公司 直肠或雾化吸入给药射干抗病毒制剂和制备及用途
CN110051758A (zh) * 2019-05-20 2019-07-26 西安高科陕西金方药业公司 一种射干抗病毒口服制剂及其制备方法
DE102019218199A1 (de) * 2019-11-25 2021-05-27 Sternenzym Gmbh & Co. Kg Verfahren zum Behandeln von Kaffeebohnen, sowie Kaffeebohne, die gemäß diesem Verfahren hergestellt wurde
WO2021180973A1 (en) * 2020-03-13 2021-09-16 Precisionbiotics Group Limited Bifidobacterium longum
WO2022006446A1 (en) * 2020-07-02 2022-01-06 The Uab Research Foundation Compositions and methods of treating conditions
IT202000018949A1 (it) * 2020-08-03 2022-02-03 Arterra Bioscience S P A Estratto derivato da bucce di punica granatum per la prevenzione e il trattamento di infezioni virali
IT202100010409A1 (it) * 2021-04-23 2022-10-23 Esserre Pharma Srl Composizione comprendente un fitocomplesso da melograno e suoi usi
CN115154502B (zh) * 2022-08-02 2023-11-03 黑龙江乌苏里江制药有限公司 一种抗炎组合物及其制备方法和应用
RS20240952A1 (sr) * 2024-08-28 2026-03-31 4Upharma Drustvo Sa Ogranicenom Odgovornoscu Beograd Biljni preparat i njegova primena kod prehlade i gripa

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
RU2033160C1 (ru) * 1991-04-08 1995-04-20 Апуховская Лариса Ивановна Способ производства витамина d3 -белкового препарата "видеин"
GB9203535D0 (en) * 1992-02-19 1992-04-08 Leo Pharm Prod Ltd Novel treatment iii
US6187764B1 (en) * 1997-05-05 2001-02-13 Angelina Pinal Buttz A and D vitamins and their metabolites: A new treatment for seasonal allergic rhinitis and atopy
GB0016173D0 (en) * 2000-06-30 2000-08-23 Nestle Sa Confectionery product containing active ingredients
US7718198B2 (en) * 2001-06-20 2010-05-18 Metaproteomics, Llc Treatment modalities for autoimmune diseases
WO2003053336A2 (en) * 2001-12-19 2003-07-03 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US6572903B1 (en) * 2002-05-08 2003-06-03 4 Seasons Wildlife Nutrition, Llc Wildlife nutritional supplement
AU2004207720A1 (en) * 2003-01-31 2004-08-12 Teijin Pharma Limited Crystal of (23S)-1alpha-hydroxy-27-nor-25-methylenevitamin D3-26,23-lactone and process for producing the same
RU2241437C1 (ru) * 2003-04-28 2004-12-10 Открытое акционерное общество "Косметическое объединение "Свобода" Зубная паста "пародонтол" с экстрактом зеленого чая, фтором, витаминами а и е
KR20040101695A (ko) * 2003-05-26 2004-12-03 (주)헬스마스터 산모용 특수영양식품
US20050053673A1 (en) * 2003-09-05 2005-03-10 Shrirang Netke Composition and method for facilitating bone healing
JP2005239694A (ja) * 2004-02-27 2005-09-08 Taiyo Kagaku Co Ltd 抗ストレス組成物
US20050260285A1 (en) * 2004-05-21 2005-11-24 Dimateeo-Leggio Giovina Healthy prostate formula
WO2006048457A1 (en) * 2004-11-05 2006-05-11 Dsm Ip Assets B.V. Probiotica and polyphenol
RU2290943C2 (ru) * 2004-12-20 2007-01-10 Дмитрий Николаевич Мясников Композиция, обладающая тонизирующим действием
US7442394B2 (en) * 2005-05-02 2008-10-28 University Of South Florida Combined effects of nutrients on proliferation of stem cells
CA2549446A1 (en) * 2005-06-07 2006-12-07 Vivabody Formulations Ltd. Diet supplement for burning additional calories, providing sustained energy, supporting weight loss, and/or improving mental focus
WO2007059960A1 (en) * 2005-11-25 2007-05-31 Dsm Ip Assets B.V. Use of 25-hydroxy vitamin d3 to improve vitality of animals
EP1891944A1 (en) * 2006-07-24 2008-02-27 Association pour la recherche à l'IGBMC (ARI) Use of Vitamin D3 agonist in a mammalian model for atopic diseases and of Vitamin D3 antagonists for the treatment of atopic diseases
KR20190028822A (ko) * 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
US8318708B2 (en) * 2007-11-06 2012-11-27 Salk Institute For Biological Studies Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosis

Also Published As

Publication number Publication date
US20090060879A1 (en) 2009-03-05
AU2008296311A1 (en) 2009-03-12
CN101801389A (zh) 2010-08-11
EP2194989A1 (en) 2010-06-16
WO2009032888A3 (en) 2009-12-03
WO2009032887A1 (en) 2009-03-12
MX2010002410A (es) 2010-03-26
WO2009032888A2 (en) 2009-03-12
CN101795693A (zh) 2010-08-04
MX2010002498A (es) 2010-03-26
CA2698517A1 (en) 2009-03-12
US20090060878A1 (en) 2009-03-05
AU2008296311B2 (en) 2014-07-03
EP2194990A2 (en) 2010-06-16
RU2010105123A (ru) 2011-10-20
RU2010105122A (ru) 2011-10-10
BRPI0816465A2 (pt) 2015-03-24
AU2008296310A1 (en) 2009-03-12
RU2479313C2 (ru) 2013-04-20
CA2698514A1 (en) 2009-03-12
RU2479316C2 (ru) 2013-04-20

Similar Documents

Publication Publication Date Title
BRPI0816350A2 (pt) Composições orais, produtos e métodos de uso
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
PT2963031T (pt) Pró-fármacos de tetrahidrocanabinol, composições compreendendo pró-fármacos de tetrahidrocanabinol e métodos de utilização dos mesmos
BRPI0818003A2 (pt) inibidores de csf-1r, composições e métodos de uso
SMT201500213B (it) Alcune triazolopirazine, loro composizioni e metodi d'uso
BRPI0908792A2 (pt) Composição, e, uso de uma combinação
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0917315A2 (pt) anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica
BRPI0914343A2 (pt) composição, produto, uso da composição e método
BRPI0812159A2 (pt) inibidores de csf-1r, composições e métodos de uso
BRPI0913086A2 (pt) Composições antimicrobianas e métodos de uso
BRPI0923836A2 (pt) Composições farmacêuticas orais contendo opióide e métodos
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
HUE065114T2 (hu) Monoklórtrifluorpropén vegyületek és készítmények és eljárások azok alkalmazásával
BRPI0913726A2 (pt) rapalogs, composições farmacêuticas, métodos de preparo e uso dos mesmos
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI1014914A2 (pt) Composição contendo trehalulose, sua preparação e uso
BRPI1014316A2 (pt) composição, e, uso de uma composição
BRPI0906253A2 (pt) Composição de dentifrício, e, uso de uma composição
IL200153A (en) History of Ethnon, including and use of pharmaceutical preparations

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.